Question 1

What is hereditary transthyretin-mediated amyloidosis (hATTR)?

Accepted Answer

Hereditary transthyretin?mediated amyloidosis (hATTR) is a rare, autosomal dominant disease caused by mutations in the TTR gene. These mutations result in misfolded transthyretin proteins that form amyloid deposits in tissues-damaging nerves, heart, kidneys, eyes, and more.
Source: NCBI GeneReviews/NLM

Question 2

What is polyneuropathy of hereditary transthyretin-mediated amyloidosis?

Accepted Answer

Polyneuropathy in hATTR (also called familial amyloid polyneuropathy, FAP) arises from amyloid deposits in peripheral nerves, causing numbness, tingling, burning pain, motor weakness, autonomic dysfunction, and often bilateral carpal tunnel syndrome.
Source: Wikipedia (FAP/ATTRv article)

Question 3

What are the early warning signs and symptoms of hATTR amyloidosis?

Accepted Answer

Early signs often include sensory symptoms-paresthesia and pain-in feet and hands, weight loss, dizziness, fatigue, and autonomic issues (e.g. GI symptoms, orthostatic hypotension). As disease advances, cardiomyopathy, kidney or ocular involvement may develop.
Source: Verywell?Health

Question 4

How is hereditary transthyretin amyloidosis diagnosed?

Accepted Answer

Diagnosis usually involves a combination of genetic testing, tissue biopsy (to detect amyloid deposits), and imaging tests such as echocardiograms or nerve conduction studies. Early diagnosis is essential to slow disease progression and start treatment options.

Question 5

How common is hereditary transthyretin amyloidosis and who is at risk?

Accepted Answer

Though rare, hATTR affects roughly 50,000 people worldwide. Prevalence varies by population-higher in Northern Portugal (?1 in 538), or among individuals of African (TTR V122I mutation), Portuguese, Irish, Japanese, or Swedish origin.
Source: Rare Disease Advisor

Question 6

What is the typical outlook for someone living with hATTR amyloidosis?

Accepted Answer

Prognosis depends on age of onset, mutation type, and organ involvement. Untreated, median survival is about 7–10 years from symptom onset. Early intervention with disease-modifying therapies significantly slows progression and improves quality of life.
Source: Verywell?Health

Question 7

What complications can occur in advanced hereditary amyloidosis?

Accepted Answer

Without treatment, hATTR can lead to serious complications including heart failure, severe nerve damage, and gastrointestinal dysfunction. Advanced stages may affect mobility, blood pressure regulation, and digestion, significantly impacting daily living.

Question 8

What’s the difference between hereditary and wild-type transthyretin amyloidosis?

Accepted Answer

Hereditary ATTR (hATTR) is genetically inherited and often starts earlier, affecting nerves and heart. Wild-type ATTR (wtATTR) develops sporadically in older adults (usually men >?60), primarily causing cardiac disease without major nerve involvement.
Source: Verywell?Health

Question 9

Can hATTR amyloidosis be passed down to children?

Accepted Answer

Yes-hATTR is inherited in an autosomal dominant pattern, giving each child a 50% chance of inheriting the mutated TTR gene. Genetic counseling is strongly recommended.
Source: Verywell?Health

Question 10

How is polyneuropathy different from cardiomyopathy in hATTR?

Accepted Answer

Polyneuropathy (hATTR?PN) affects peripheral nerves-causing sensory, motor, and autonomic symptoms. Cardiomyopathy (hATTR?CM) affects the heart muscle-leading to restrictive heart failure, arrhythmias, and edema. Many patients exhibit a mixed phenotype involving both systems.
Source: HCPLive

Hereditary Transthyretin Mediated Amyloidosis Medications